Data integrity – Page 30

How to Meet 21 CFR Part 11 Expectations for Electronic Records

Addressing Compliance with 21 CFR Part 11 for Electronic Records In the evolving landscape of pharmaceutical manufacturing, compliance with regulatory standards is paramount, particularly in the realm of electronic records…

Step-by-Step Guide to Managing Missing Audit Trail Archives Under ALCOA+ Expectations

Practical Approach for Managing Missing Audit Trail Archives Under ALCOA+ Standards In the pharmaceutical industry, maintaining data integrity is paramount, especially under the ALCOA+ principles which emphasize the need for…

Electronic Records vs Paper Records: Compliance Risks in Pharma Operations

Addressing the Compliance Dilemma of Electronic Records and Signatures in Pharma Operations In the fast-evolving landscape of pharmaceutical manufacturing, the transition from paper-based systems to electronic records and electronic signatures…

Why Disaster Recovery for GxP Systems Happens and How QA Teams Should Control It

Understanding Disaster Recovery for GxP Systems and Effective Control by QA Teams In today’s pharmaceutical manufacturing landscape, the integrity of Good Practice (GxP) systems and the data they manage is…

How to Validate Electronic Signatures for GMP Approval Workflows

Validating Electronic Signatures for Compliance in GMP Workflows Many pharmaceutical organizations encounter challenges related to the use of electronic signatures in their GMP workflows. As regulations grow stricter regarding data…

Inspection-Ready Approach to Data Retention Policy Gaps in Pharmaceutical Operations

Addressing Gaps in Data Retention Policies for Pharmaceutical Operations In an environment governed by stringent regulatory requirements, pharmaceutical companies face significant challenges when it comes to adhering to data retention…

ERES Compliance Checklist for GMP Computerized Systems

Comprehensive Guide to Ensuring Compliance with ERES for GMP Computerized Systems In the realm of pharmaceutical manufacturing, compliance with regulatory requirements concerning electronic records and electronic signatures (ERES) is paramount.…

Archive Readability Failures: Root Causes, GMP Risks, and CAPA Controls

Addressing Readability Failures in Archive Data: Causes, Risks, and Remedial Measures In the pharmaceutical industry, the robustness of your data management processes is paramount, especially concerning GMP backup archival data…

Electronic Records and Electronic Signatures in Pharma: Practical Compliance Guide

Ensuring Compliance with Electronic Records and Signatures in Pharma: A Practical Guide The digitization of pharmaceutical operations has brought forth significant improvements, particularly in the management of electronic records and…

How to Prevent Backup Restore Testing in Backup, Archival & Data Retention

Strategies for Preventing Backup Restore Testing in GMP Data Management In the pharmaceutical manufacturing environment, regulatory compliance is paramount, particularly when it comes to managing data integrity during backup and…

Step-by-Step Guide to Managing Access Control Effectiveness Checks Under ALCOA+ Expectations

Step-by-Step Approach to Ensuring Access Control Effectiveness under ALCOA+ Guidelines In the dynamic environment of pharmaceutical manufacturing and quality assurance, safeguarding data integrity is paramount. One critical aspect of this…

Why Access Control Mock Audit Happens and How QA Teams Should Control It

Understanding Access Control Mock Audits and How QA Teams Can Manage Them Effectively In today’s regulatory environment, pharmaceutical companies must maintain strict GxP user access control to ensure data integrity…